who medicines strategy - libdoc.who.int - World Health Organization

MEDICINES AND PUBLIC HEALTH | 21> Intensive work on access to medicines forHIV/AIDS, TB, malaria, and other prioritydiseases, with a focus on selection, regulation,quality assessment, prices, and monitoring oftrade agreements.> Expansion of information on comparativemedicine prices worldwide and developmentof a new price survey methodology to helphealth systems and consumers become moreinformed buyers of quality medicines.> Launch of the first global training programmeon GMP to improve the quality of medicinesproduction worldwide.> Creation of a programme for qualityassessment for priority products(prequalification) which now covers HIV/AIDS, TB, and malaria.> Expansion of the WHO InternationalProgramme for Monitoring Drug Safety, whichalso marked its 25 th year and now extends to72 countries.OBJECTIVES AND EXPECTEDOUTCOMES FOR 2004-2007The WMS 2004-2007 retains the same fourobjectives as the previous strategy, but dividesexpected outcomes into seven components.These objectives and components reflect whatis needed in countries to achieve the essentialmedicines vision. WHO’s work for the nextfour years is then defined in terms of support forcountries to achieve these aims.> Revision of the essential medicines selectionprocess to ensure a more evidence-based,independent, and transparent process.Reasons for selection are published on theWHO Medicines Library website, togetherwith comparative information on prices andthe WHO Model Formulary.> Development of comprehensive trainingprogrammes on rational use of medicines,including programmes on problembasedtherapy, rational use in communityprescribing, pharmacoeconomics, and drugsand therapeutics committees.> Launch of a campaign to raise awarenessabout the dangers of counterfeit andsubstandard medicines.